GHDX News and Press, Genomic Health Inc. From 07/24/19

Gainers:  DelMar Pharmaceuticals (NASDAQ: DMPI ) +39%.  SigmaTron International (NASDAQ: SGMA ) +22% . Nuvectra Corporation (NASDAQ: NVTR ) +20% . Teradyne (NASDAQ: TER ) +18% . Manhattan Associates (NASDAQ: MANH ) +18% . Snap (NYSE: SNAP ) +16% . Acasti Pharma (NASDAQ: ACS...

NEW YORK , July 23, 2019 /PRNewswire/ -- Genomic Health Inc. (NASD: GHDX) will replace Electronics For Imaging Inc. (NASD: EFII) in the S&P SmallCap 600 effective prior to the open of trading on Monday, July 29 . Siris Capital Group LLC acquired Electronics For Imaging in a deal...

Genomic Health (NASDAQ: GHDX ) is up 7.9% after hours alongside news that it's joining the S&P SmallCap 600 index . More news on: Genomic Health, Inc., Electronics for Imaging, Inc., Healthcare stocks news, Tech stocks news, Stocks on the move Read more ...

REDWOOD CITY, Calif. , June 20, 2019 /PRNewswire/ -- Genomic Health announced today that the German Federal Joint Committee (G-BA) issued a positive reimbursement decision for the Oncotype DX Breast Recurrence Score ® test during its plenary meeting session on June 20 . Accordi...

· Additional detail in patients age 50 or younger presented in oral session at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting · TAILORx continues to elevate Oncotype DX ®  test to a new global standard with increasing utilisation and reimbursement ...

Additional Detail in Patients Age 50 or Younger Presented Today in Oral Session at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting TAILORx Continues to Elevate Oncotype DX ® to a New Global Standard with Increasing Utilization and Reimbursement REDWOOD CI...

New ASCO Recommendations Increase Proportion of Women Who Can Be Spared Chemotherapy Based on Landmark TAILORx and NSABP B-20 Randomized Clinical Trials Additional Secondary Analysis of TAILORx Trial to be Presented at ASCO Annual Meeting Today REDWOOD CITY, California , June 3, 20...

REDWOOD CITY, Calif. , May 29, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that management will present at the Jefferies 2019 Healthcare Conference in New York City on Wednesday, June 5, 2019 at 2 p.m. Eastern Time . To access the live and subsequently ...

Start Time: 16:30 End Time: 17:15 Genomic Health, Inc. (GHDX) Q1 2019 Earnings Conference Call May 07, 2019, 16:30 PM ET Company Participants Kim Popovits - Chairman, CEO and President Brad Cole - CFO Fred Pla - COO Emily Faucette - VP, Corporate Communications & IR ...

Genomic Health (NASDAQ: GHDX ): Q1 GAAP EPS of $0.34 beats by $0.07 . More news on: Genomic Health, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...